HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eilers, H. Articles by Schumacher, M. A. Search for Related Content PubMed PubMed Citation Articles by Eilers, H. Articles by Schumacher, M. A.

Opioid-induced Respiratory Depression: Are 5-HT_4a Receptor Agonists the Cure?

¹ Departments of Anesthesia and Perioperative Care, and
² Oral and Maxillofacial Surgery, University of California, San Francisco, CA, 94143

SUMMARY

µ-Opioid receptor agonists are commonly utilized as analgesics for treatment of acute pain and some chronic pain syndromes. In addition to their outstanding effectiveness, opioids, unfortunately, promote respiratory depression. Indeed, opioid–induced respiratory depression can result in hypoventilation and neurologic injury, and may arise as a consequence of µ-opioid receptor–mediated blockade of specialized respiratory neurons in the brainstem. Manzke and coworkers have suggested that the serotonin receptor subtype 5-HT_4a (5-HT_4aR) could serve as a useful therapeutic target for the treatment or prevention of opioid–induced respiratory depression. This hypothesis derives from the finding that the 5-HT_4aR and the µ-opioid receptors affect the intracellular concentration of cyclic AMP in opposing ways. The findings are a significant milestone in ongoing efforts to understand the analgesia–ventilation link.

This article has been cited by other articles:

				K. T. S. Pattinson Opioids and the control of respiration Br. J. Anaesth., June 1, 2008; 100(6): 747 - 758. [Abstract] [Full Text] [PDF]